ProCE Banner Activity

New Immunotherapeutic Combinations for Hematologic Malignancies

Clinical Thought
Explore the latest immunotherapeutic combinations for treatment of hematologic malignancies.

Released: February 26, 2016

Expiration: February 24, 2017

No longer available for credit.

Share

Faculty

Jonathan Webster

Jonathan Webster, MD

Fellow
Division of Hematologic Malignancies
Department of Oncology
Johns Hopkins University
Baltimore, Maryland

Provided by

Jointly provided by Postgraduate Institute for Medicine and Clinical Care Options, LLC
ProCE Banner

Supporters

This activity is supported by an educational donation from

Amgen, Inc.

Faculty Disclosure

Primary Author

Jonathan Webster, MD

Fellow
Division of Hematologic Malignancies
Department of Oncology
Johns Hopkins University
Baltimore, Maryland

Jonathan Webster, MD, has no real or apparent conflicts of interest to disclose.